BiotechTubeBiotechTube
Istesso

Istesso

Phase 2
Oxford, United KingdomFounded 2018istesso.co.uk

Istesso is the lead company in creating a programmed disease resolution to treat a wide range of chronic diseases.

Founded
2018
Focus
Small Molecules

About

Istesso is the lead company in creating a programmed disease resolution to treat a wide range of chronic diseases.

Funding History

1

Total raised: $30M

Series A$30MForbionJan 15, 2022

Company Info

TypePrivate
Founded2018
LocationOxford, United Kingdom
StagePhase 2

Contact

istesso.co.uk

Sectors

Small Molecule Drugs
SIMILAR COMPANIES
Abbexa
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Accentus Medical
Pre-clinical · Oxford
AbOliGo
AbOliGo
Pre-clinical · London
Bigespas
Bigespas
Pre-clinical · London
Actimed Therapeutics
Actimed Therapeutics
Pre-clinical · London
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile